PLTR: Down 38% and Still Wildly Overvalued
Key Takeaways
- Palantir trades at 203x earnings and 302x sales despite a 38% decline from its all-time high of $207.52.
- Q4 2025 revenue hit $1.41 billion with a 40.9% operating margin, but this growth is fully priced into the stock.
- The balance sheet is pristine with virtually no debt and $7.2 billion in working capital, yet FCF yield is just 0.18%.
- Analyst estimates project $0.85 EPS by 2028, which still implies a forward PE above 150x at current prices.
- Avoid until valuation compresses to below 80x earnings through either price decline or sustained earnings growth.
$128 per share. A 38% decline from the $207 all-time high. And Palantir Technologies still trades at 203 times earnings.
The stock has shed roughly $180 billion in market capitalization since its peak, yet the valuation remains disconnected from the underlying business economics. At a $293 billion market cap, investors are paying more than 300 times trailing sales for a company that generated $4.5 billion in revenue last year. The repricing has been painful for momentum traders, but it hasn't been nearly painful enough for value investors.
Palantir's Q4 2025 results were genuinely impressive: $1.41 billion in revenue, a 40.9% operating margin, and $609 million in net income. The problem isn't the business. The problem is that the stock price assumes a decade of flawless execution that no enterprise software company in history has delivered.
Valuation: The Numbers Don't Work
Palantir trades at 203x trailing earnings, 57x book value, and an EV/EBITDA of 727x based on Q4 annualized figures. For context, the S&P 500 software sector averages roughly 35x earnings and 15x EV/EBITDA. If you're unsure how to interpret these ratios, our guide to stock valuation metrics breaks down what each one actually tells you.
The stock's price-to-sales ratio stands at 302x on a trailing basis. Even using the most generous forward estimates — analysts project $0.85 EPS by fiscal 2028 — the forward PE two years out still exceeds 150x. That's not a growth premium. That's a prayer.
The Graham Number — a rough intrinsic value estimate based on earnings and book value — puts PLTR at $4.21 per share. The stock trades at $128. That's a 30x premium to what conservative valuation math suggests.
Earnings: Genuine Strength, Fully Priced
Credit where due: Palantir's earnings growth trajectory has been remarkable. Revenue accelerated from $884 million in Q1 2025 to $1.41 billion in Q4 — a 59% increase across four quarters. Diluted EPS climbed from $0.08 to $0.24 over the same period.
Full-year 2025 revenue reached $4.48 billion with $1.63 billion in net income. Gross margins held above 80% every quarter, and operating margins expanded from 19.9% in Q1 to 40.9% in Q4 as Palantir demonstrated genuine operating leverage.
The issue is that none of this is a secret. The market has priced in not just current earnings power but an extrapolation of this growth rate extending indefinitely. At $128, buyers need revenue to compound above 30% annually for years while margins hold at historically unprecedented levels.
Balance Sheet: The One Bright Spot
Palantir's balance sheet is legitimately strong. The company carries virtually no debt (debt-to-equity of just 0.056) and holds $7.18 billion in working capital. The current ratio stands at 7.1x — this is a fortress balance sheet by any measure.
Free cash flow reached $0.32 per share in Q4, with a 98% conversion rate from operating cash flow. Capex requirements are minimal (less than 1% of revenue), which means nearly all operating profit converts to cash.
The catch? Even with this pristine balance sheet, the FCF yield is just 0.18%. You'd earn more parking your money in a savings account. Cash generation is strong in absolute terms but trivial relative to what investors are paying for the equity.
The AI Narrative vs. Enterprise Reality
Palantir's growth story rests on the Artificial Intelligence Platform (AIP), which has driven accelerating commercial adoption. Government contracts remain the bedrock — roughly half of revenue — but commercial growth is the bull case.
Stock-based compensation tells a more nuanced story. SBC consumed 14% of revenue in Q4 2025, down from 17.6% in Q1, but still diluting shareholders at a meaningful rate. The weighted average diluted share count was 2.57 billion in Q4. ROE sits at just 8.2% despite eye-watering margins, because the enormous market cap dwarfs the actual equity base.
The competitive moat is real but narrower than bulls acknowledge. Palantir's government contracts create switching costs, but the commercial AIP product competes against every major cloud provider's AI platform — including Salesforce's Agentforce, which targets the same enterprise AI market at a fraction of Palantir's valuation. Microsoft, Google, and Amazon are not standing still.
What Analysts Are Missing
Wall Street's consensus is split. Some analysts have turned bullish after the 38% drawdown, arguing that Palantir's unique government-commercial hybrid positions it to capture enterprise AI spending.
Estimates project EPS growth to roughly $0.85 by fiscal 2028, implying a three-year earnings growth rate of about 35% annually. That growth rate would need to sustain well beyond 2028 to justify the current multiple.
The risk that nobody discusses: concentration. Palantir's government revenue depends on continued defense and intelligence spending growth. A budget sequestration, a shift in political priorities, or simply slower-than-expected rollout of AIP across federal agencies could crater the growth narrative overnight. Earnings announcement is scheduled for May 4 — any guidance miss at these multiples would be devastating.
The Verdict: Gravity Hasn't Finished
Palantir is a good business trading at an absurd valuation. The 38% decline hasn't corrected the fundamental mismatch between price and earnings power — it's merely brought the PE from stratospheric to merely extreme.
For the stock to deliver acceptable returns from $128, you need to believe revenue can reach $15-20 billion within five years while maintaining 40%+ operating margins and minimal dilution. That's not impossible, but it requires everything to go right simultaneously.
The volume spike to 116 million shares (more than double the average) signals capitulation hasn't completed. When speculative premiums unwind, they rarely stop at 'expensive.' They overshoot to 'fairly valued' or worse. This is part of a broader pattern — the Mag 7 divergence is creating stark winners and losers among mega-cap tech names.
Conclusion
Palantir's technology is differentiated, its balance sheet is clean, and its earnings trajectory is genuinely impressive. None of that matters at 200x earnings.
Avoid the stock at current levels. A reasonable entry point requires either a further 50-60% decline to bring the PE below 80x, or two to three years of 30%+ earnings growth that the market hasn't already priced in. The May 4 earnings report will be the next catalyst — and at these multiples, anything less than perfection sends the stock lower.
Frequently Asked Questions
Sources & References
www.sec.gov
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Consult qualified professionals before making investment decisions.